Skip to main content
Tech.euFundingExplorerBeta

Cumulus Neuroscience

Cumulus Neuroscience has created a next-generation integrated physiological and digital biomarker platform.

Cumulus Neuroscience has raised €11M across 2 funding rounds from 7 investors, most recently a round in Jul 2025. Based in Belfast, Ireland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€11M
€10,684,837
Funding rounds
2
Investors
7
distinct backers
Active since
2021-05
latest 2025-07

Funding by year

EUR raised per year
Cumulus Neuroscience — funding by year — interactive chart.
Data table
Cumulus Neuroscience — funding by year
2021€6.9M
2025€3.8M

Signals

High confidence
Raise-next likelihood36
base rate 30% for Other
  • ▲ In typical raise window
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood16
base rate 11% (2+ rounds)
  • ▲ 5y since founding (typical exit age)
  • ▲ Recent equity round, but funding momentum is down (may be rescue financing)

Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Related news

Similar companies

same sector or country

Global coverage: FundingData